Latest filings (excl ownership)
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
14 May 24
10-Q
2024 Q1
Quarterly report
14 May 24
EFFECT
Notice of effectiveness
3 Apr 24
S-8
Registration of securities for employees
29 Mar 24
POS AM
Prospectus update (post-effective amendment)
28 Mar 24
10-K
2023 FY
Annual report
28 Mar 24
8-K
Other Events
18 Jan 24
8-K
Material Modifications to Rights of Security Holders
2 Jan 24
DEFA14A
Additional proxy soliciting materials
28 Dec 23
8-K
Material Modifications to Rights of Security Holders
28 Dec 23
DEFA14A
Additional proxy soliciting materials
19 Dec 23
8-K
Departure of Directors or Certain Officers
19 Dec 23
DEFA14A
Additional proxy soliciting materials
29 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
ARS
2022 FY
Annual report to shareholders
26 Oct 23
DEF 14A
Definitive proxy
26 Oct 23
PRE 14A
Preliminary proxy
16 Oct 23
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
13 Oct 23
SC TO-I/A
Issuer tender offer statement (amended)
14 Sep 23
8-K
Pasithea Therapeutics Corp. Announces Final Results of Tender Offer
14 Sep 23
SC TO-I/A
Issuer tender offer statement (amended)
24 Aug 23
SC TO-I/A
Issuer tender offer statement (amended)
21 Aug 23
CORRESP
Correspondence with SEC
21 Aug 23
UPLOAD
Letter from SEC
15 Aug 23
SC TO-I/A
Issuer tender offer statement (amended)
14 Aug 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
SC TO-I
Issuer tender offer statement
9 Aug 23
SC TO-C
Information about tender offer
20 Jul 23
8-K
Pasithea Therapeutics Announces Intention to Commence a $4.0 Million Tender Offer for its Common Stock at Price of $0.70 per Share in Cash
20 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Jul 23
424B3
Prospectus supplement
6 Jun 23
EFFECT
Notice of effectiveness
6 Jun 23
CORRESP
Correspondence with SEC
1 Jun 23
UPLOAD
Letter from SEC
19 May 23
S-3
Shelf registration
12 May 23
10-Q
2023 Q1
Quarterly report
12 May 23
EFFECT
Notice of effectiveness
20 Apr 23
CORRESP
Correspondence with SEC
17 Apr 23
UPLOAD
Letter from SEC
4 Apr 23
Latest ownership filings
4/A
Tiago Marques
5 Apr 24
4/A
Simon Dumesnil
5 Apr 24
4/A
Daniel H Schneiderman
5 Apr 24
4/A
Emer Leahy
5 Apr 24
4/A
Alfred J Novak
5 Apr 24
4/A
Graeme Martin Currie
5 Apr 24
4/A
LAWRENCE STEINMAN
5 Apr 24
4
LAWRENCE STEINMAN
1 Mar 24
4
Daniel H Schneiderman
1 Mar 24
4
Alfred J Novak
1 Mar 24
4
Tiago Marques
1 Mar 24
4
Emer Leahy
1 Mar 24
4
Simon Dumesnil
1 Mar 24
4
Graeme Martin Currie
1 Mar 24
3
Graeme Martin Currie
3 Jul 23
SC 13D
STEINMAN LAWRENCE
8 Jun 23
4/A
LAWRENCE STEINMAN
6 Jun 23
4
LAWRENCE STEINMAN
6 Jun 23
SC 13G/A
Manning Paul B
15 Feb 23
3
Paul B Manning
14 Feb 23
SC 13G/A
Khire Uday
13 Jan 23
SC 13D/A
Camac Fund, LP
10 Jan 23
SC 13D/A
Camac Fund, LP
14 Dec 22
4
LAWRENCE STEINMAN
28 Nov 22
4
Tiago Marques
28 Nov 22
4
LAWRENCE STEINMAN
22 Nov 22
4
Simon Dumesnil
17 Nov 22
SC 13D/A
Camac Fund, LP
1 Nov 22
4
LAWRENCE STEINMAN
26 Oct 22
4
Alfred J Novak
24 Oct 22
4
Tiago Marques
21 Oct 22
SC 13G
Khire Uday
20 Oct 22
4
David Delaney
19 Oct 22
4
LAWRENCE STEINMAN
17 Oct 22
4
Daniel H Schneiderman
12 Oct 22
4
Eric Shahinian
30 Sep 22
3
Alfred J Novak
20 Sep 22
4
Eric Shahinian
6 Sep 22
SC 13D/A
Camac Fund, LP
6 Sep 22
SC 13D/A
Camac Fund, LP
1 Sep 22